Vasarya Therapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 5

Vasarya Therapeutics General Information

Description

Opearator of a biotechnology company intended to discover and translate novel therapeutics by leveraging the power of mechanobiology. The company specializes in developing a more efficacious, safer drug for tissue remodeling disorders by leveraging opportunities in mechanobiology.

Contact Information

Website
www.vasarya.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 824 Village Road
  • Charlottesville, VA 22903
  • United States
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 824 Village Road
  • Charlottesville, VA 22903
  • United States

Vasarya Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vasarya Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 01-Apr-2026 Completed Generating Revenue
4. Accelerator/Incubator 11-Aug-2025 Completed Pre-Clinical Trials
3. Early Stage VC 18-Feb-2025 Completed Pre-Clinical Trials
2. Grant 01-Jan-2024 $296K Completed Pre-Clinical Trials
1. Grant $500K Completed Pre-Clinical Trials
To view Vasarya Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Vasarya Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vasarya Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Portal Innovations Venture Capital Minority
Cville BioHub Accelerator/Incubator
Blackbird Laboratories Accelerator/Incubator Minority
University of Virginia University Minority
National Institutes of Health Government
To view Vasarya Therapeutics’s complete investors history, request access »

Vasarya Therapeutics FAQs

  • When was Vasarya Therapeutics founded?

    Vasarya Therapeutics was founded in 2022.

  • Where is Vasarya Therapeutics headquartered?

    Vasarya Therapeutics is headquartered in Charlottesville, VA.

  • What is the size of Vasarya Therapeutics?

    Vasarya Therapeutics has 4 total employees.

  • What industry is Vasarya Therapeutics in?

    Vasarya Therapeutics’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Vasarya Therapeutics a private or public company?

    Vasarya Therapeutics is a Private company.

  • What is Vasarya Therapeutics’s current revenue?

    The current revenue for Vasarya Therapeutics is .

  • How much funding has Vasarya Therapeutics raised over time?

    Vasarya Therapeutics has raised $75K.

  • Who are Vasarya Therapeutics’s investors?

    Portal Innovations, Cville BioHub, Blackbird Laboratories, University of Virginia, and National Institutes of Health have invested in Vasarya Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process